Susanna Ulahannan, MD, MMed
Associate Director, Phase 1 Program, Sarah Cannon Research Institute at the Stephenson Cancer Center
Dr. Ulahannan joined Sarah Cannon Research Institute (SCRI) at the Stephenson Cancer Center in 2017 and serves as associate director of the phase 1 program. In her role, she focuses on phase 1 clinical trials and gastrointestinal malignancies.
Ulahannan received her medical degree and a Master of Medicine from Sahlgrenska Akademin, Goteborg University in Sweden, completed her residency at Johns Hopkins University and a fellowship in hematology-oncology at the National Cancer Institute/National Institutes of Health.
Before joining SCRI at the Stephenson Cancer Center, Dr. Ulahannan was a hematology-oncology assistant professor of medicine at the Stephenson Cancer Center - University of Oklahoma Health Sciences Center. She is board certified in hematology, medical oncology, and internal medicine.